Versant Capital Management »

Oric Pharmaceuticals shares owned by Versant Capital Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.6k 720 12.00
2025-06-30 $7.3k 720 10.15
2024-12-31 $3.9k 478 8.07

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
EcoR1 Capital
VR Adviser
Viking Global Investors
Pfizer
BlackRock
Vanguard Group
Sr One Capital Management
Alkeon Capital Management
NEA Management Company
OrbiMed Advisors
Column Group
Vivo Capital
Point72 Asset Management
FMR

View all funds holding Oric Pharmaceuticals